Nora Henrikson (she/her) is an associate investigator at Kaiser Permanente Washington Health Research Institute. She leads a research portfolio focused on interventions to improve cancer care delivery, health equity, and patient outcomes.
Her current research explores methods for improving risk notification and cascading genetic testing for family members of people with hereditary cancers as well as interventions to mitigate cancer-related financial hardship. Dr. Henrikson also leads systematic evidence reviews on cancer screening and behavioral counseling with the Kaiser Permanente Evidence-based Practice Center.
Dr. Henrikson holds affiliate faculty appointments at the University of Washington School of Public Health in the Department of Health Systems and Population Health, and the Institute for Public Health Genetics. She is also an associate professor at the Bernard J. Tyson Kaiser Permanente School of Medicine.
She has a PhD from the University of Washington School of Public Health’s Institute for Public Health Genetics, an MPH from the University of North Carolina at Chapel Hill, and a BA (sociology) from Lehigh University.
Genetic testing for cancer risk, cancer-related financial hardship
Financial hardship, health equity
Quantitative, qualitative, and mixed methods; intervention design; implementation science
Systematic review and evidence synthesis; epidemiology
Social, ethical, and policy implications of genomics and precision health
Henrikson NB, Anderson ML, Hubbard RA, Fishman P, Grossman DC. Employee knowledge of value-based insurance design benefits. Am J Prev Med. 2014;47(2):115-22. doi: 10.1016/j.amepre.2014.03.005. Epub 2014 Jun 17. PubMed
Henrikson N, Tuzzio L, Loggers ET, Miyoshi J, Buist DS. Patient and oncologist discussions about cancer care costs. Support Care Cancer. 2014 Apr;22(4):961-7. doi: 10.1007/s00520-013-2050-x. Epub 2013 Nov 26. PubMed
Jackson ML, Henrikson NB, Grossman DC. Evaluating Washington State’s Immunization Information System as a research tool. Academ Pediatr. 2014 Jan 1;14(1):71-6. doi: 10.1016/j.acap.2013.10.002.
Henrikson NB, Skelly AC. Economic studies part II: evaluating quality. Evid Based Spine Care J. 2013 Apr;4(1):2-5. doi: 10.1055/s-0033-1341594. PubMed
Henrikson NB, Skelly AC. Economic studies part I: basics and terms. Evid Based Spine Care J. 2012 Nov;3(4):7-11. doi: 10.1055/s-0032-1328137. PubMed
Grossman D, Fishman P, Beck A, Reid R, Ritzwoller D, Martin D, Henrikson N, Hubbard R, Scrol A. Quasi-experimental evaluation of a value-based health plan design among healthcare employees. Clin Med Res. 2011;9(3-4):173-4.
Henrikson NB, Davison BJ, Berry DL. Measuring decisional control preferences in men newly diagnosed with prostate cancer. J Psychosoc Oncol. 2011;29(6):606-18. PubMed
Standaert CJ, Friedly J, Erwin MW, Lee MJ, Rechtine G, Henrikson NB, Norvell DC. Comparative effectiveness of exercise, acupuncture, and spinal manipulation for low back pain. Spine. 2011;36(21 Suppl):S120-30. PubMed
Henrikson NB, Ellis WJ, Berry DL. "It's not like I can change my mind later": reversibility and decision timing in prostate cancer treatment decision-making. Patient Educ Couns. Nov;77(2):302-7. Epub 2009 Apr 21.
Henrikson NB, Bowen D, Burke W. Does genomic risk information motivate people to change their behavior? Genome Med. 2009 Apr 2;1(4):37.
KPWHRI researchers answer questions about systematic reviews and their impact on health care guidelines.
The HCSRN conference is a venue for collaborative work to improve health and health care.
Dr. Henrikson’s Annals of Internal Medicine study describes 3 kinds of cost concerns that can affect cancer care.
Nora Henrikson discusses her latest research published in the Annals of Internal Medicine in May 2019. (Vimeo, 3:50)